EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL

INTRO: VLA2001 is a highly-purified, inactivated whole-virus SARS-CoV-2 vaccine based on a dual-adjuvant system of Alum and CpG1018 for induction of a robust immune response. The vaccine was designed using a well-established technology platform and has received full marketing authorization in Europe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wressnigg, N., Taucher, C., Eder-Lingelbach, S., Querton, B., Krammer, M., Lilja, A., Hochreiter, R., Hoffmann, M., Pöhlmann, S., Jaramillo, J.-C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Oral Session 7: COVID-19Date: Sunday, Nov 20, 2022 Time: 08:00-09:00Venue: Conference Hall #3 (CH3)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186897/
http://dx.doi.org/10.1016/j.ijid.2023.04.059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186897/
http://dx.doi.org/10.1016/j.ijid.2023.04.059

Ejemplares similares